Long-term response and time to response to pazopanib (PAZ) and sunitinib (SUN) in metastatic renal cell carcinoma (mRCC): COMPARZ subanalysis
Nizar M. Tannir, Camillo Porta, Viktor Gruenwald, Toni K. Choueiri, Qasim Ahmad, Marlene Carrasco Alfonso, Luca Dezzani, Jackie Han, Cora N. Sternberg
The University of Texas MD Anderson Cancer Center, Houston, TX
IRCCS San Matteo University Hospital Foundation, Padua, Italy
Medical School of Hannover, Hannover, Germany
Dana-Farber Cancer Institute and Brigham and Women‘s Hospital, Boston, MA
Novartis Pharmaceuticals Corporation, East Hanover, NJ
San Camillo Forlanini Hospital, Rome, Italy
Meeting: 2017 ASCO Annual Meeting Track: Genitourinary (Nonprostate) Cancer Abstract number: 4572 Citation: J Clin Oncol 35, 2017 (suppl; abstr 4572) Author(s): Nizar M. Tannir, Camillo Porta, Viktor Gruenwald, Toni K. Choueiri, Qasim Ahmad, Marlene Carrasco Alfonso, Luca Dezzani, Jackie Han, Cora N. Sternberg; The University of Texas MD Anderson Cancer...